Aarti Drugs Limited — Important, 24-10-2024: Updates

Aarti Drugs Limited has released its Q2 & H1 FY25 investor presentation. The company continues to focus on sustainable growth and long-term value creation, emphasizing its strong portfolio in APIs, formulations, and specialty chemicals. Despite a decline in revenue by 11% year-over-year, Aarti retains a robust financial position with a strategic plan for capital expansion. Key highlights include significant market presence, international diversification, and ongoing commitment to R&D and ESG initiatives.